BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36038138)

  • 1.
    Paparella AS; Cahill SM; Aboulache BL; Schramm VL
    ACS Chem Biol; 2022 Sep; 17(9):2507-2518. PubMed ID: 36038138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
    Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
    Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isofagomine Inhibits Multiple TcdB Variants and Protects Mice from
    Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
    ACS Infect Dis; 2024 Mar; 10(3):928-937. PubMed ID: 38334357
    [No Abstract]   [Full Text] [Related]  

  • 5. Human α-Defensin-6 Neutralizes
    Barthold L; Heber S; Schmidt CQ; Gradl M; Weidinger G; Barth H; Fischer S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Essential Role of Rac1 Glucosylation in
    Petersen L; Stroh S; Schöttelndreier D; Grassl GA; Rottner K; Brakebusch C; Fahrer J; Genth H
    Front Microbiol; 2022; 13():846215. PubMed ID: 35321078
    [No Abstract]   [Full Text] [Related]  

  • 7. Difference in Mono-O-Glucosylation of Ras Subtype GTPases Between Toxin A and Toxin B From
    Genth H; Junemann J; Lämmerhirt CM; Lücke AC; Schelle I; Just I; Gerhard R; Pich A
    Front Microbiol; 2018; 9():3078. PubMed ID: 30622517
    [No Abstract]   [Full Text] [Related]  

  • 8. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
    Li S; Shi L; Yang Z; Feng H
    Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
    Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
    J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TcdB of
    Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal Ion Activation of Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B.
    Genth H; Schelle I; Just I
    Toxins (Basel); 2016 Apr; 8(4):109. PubMed ID: 27089365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neutrophils are resistant to Clostridioides difficile toxin B.
    Chaves-Cordero C; Quesada-Gómez C; Chaves-Olarte E; Barquero-Calvo E
    Anaerobe; 2022 Apr; 74():102553. PubMed ID: 35346824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyknotic cell death induced by Clostridium difficile TcdB: chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity.
    Wohlan K; Goy S; Olling A; Srivaratharajan S; Tatge H; Genth H; Gerhard R
    Cell Microbiol; 2014 Nov; 16(11):1678-92. PubMed ID: 24898616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isofagomine inhibits multiple TcdB variants and protects mice from
    Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
    bioRxiv; 2023 Sep; ():. PubMed ID: 37781587
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.
    Alvin JW; Lacy DB
    J Struct Biol; 2017 Jun; 198(3):203-209. PubMed ID: 28433497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the host SLC11A1 gene by Clostridium difficile toxin B facilitates glucosylation of Rho GTPases and enhances toxin lethality.
    Feng Y; Cohen SN
    Infect Immun; 2013 Aug; 81(8):2724-32. PubMed ID: 23690404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
    Chen B; Liu Z; Perry K; Jin R
    Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
    Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
    Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.